Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Swedish Medtech söker ekonom/jurist

LEO Pharma - International Clinical Trial Manager

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.